BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33340247)

  • 1. Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas.
    Schinke H; Heider T; Herkommer T; Simon F; Blancke Soares A; Kranz G; Samaga D; Dajka L; Feuchtinger A; Walch A; Valeanu L; Walz C; Kirchner T; Canis M; Baumeister P; Belka C; Maihöfer C; Marschner S; Pflugradt U; Ganswindt U; Hess J; Zitzelsberger H; Gires O
    Mol Oncol; 2021 Apr; 15(4):1040-1053. PubMed ID: 33340247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLUG-related partial epithelial-to-mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival.
    Schinke H; Pan M; Akyol M; Zhou J; Shi E; Kranz G; Libl D; Quadt T; Simon F; Canis M; Baumeister P; Gires O
    Mol Oncol; 2022 Jan; 16(2):347-367. PubMed ID: 34382739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers.
    Pan M; Schinke H; Luxenburger E; Kranz G; Shakhtour J; Libl D; Huang Y; Gaber A; Pavšič M; Lenarčič B; Kitz J; Jakob M; Schwenk-Zieger S; Canis M; Hess J; Unger K; Baumeister P; Gires O
    PLoS Biol; 2018 Sep; 16(9):e2006624. PubMed ID: 30261040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of Slug by NF-κB is Essential for TNF-α -Induced Migration and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cells.
    Liu S; Shi L; Wang Y; Ye D; Ju H; Ma H; Yang W; Wang Y; Hu J; Deng J; Zhang Z
    Cell Physiol Biochem; 2018; 47(2):567-578. PubMed ID: 29794474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells.
    Moon JH; Lee SH; Koo BS; Kim JM; Huang S; Cho JH; Eun YG; Shin HA; Lim YC
    Oral Oncol; 2020 Dec; 111():104948. PubMed ID: 32771963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the expression of epithelial cell adhesion molecules in head and neck squamous cell carcinoma treated by definitive radiotherapy.
    Murakami N; Mori T; Nakamura S; Yoshimoto S; Honma Y; Ueno T; Kobayashi K; Kashihara T; Takahashi K; Inaba K; Okuma K; Igaki H; Nakayama Y; Itami J
    J Radiat Res; 2019 Nov; 60(6):803-811. PubMed ID: 31361893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Epithelial-Mesenchymal Transition Regulating Transcription Factors in Head and Neck Squamous Cell Carcinomas.
    Göppel J; Möckelmann N; Münscher A; Sauter G; Schumacher U
    Anticancer Res; 2017 Oct; 37(10):5435-5440. PubMed ID: 28982853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinoma.
    Cappellesso R; Marioni G; Crescenzi M; Giacomelli L; Guzzardo V; Mussato A; Staffieri A; Martini A; Blandamura S; Fassina A
    Histopathology; 2015 Oct; 67(4):491-500. PubMed ID: 25684546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma.
    Baumeister P; Hollmann A; Kitz J; Afthonidou A; Simon F; Shakhtour J; Mack B; Kranz G; Libl D; Leu M; Schirmer MA; Canis M; Belka C; Zitzelsberger H; Ganswindt U; Hess J; Jakob M; Unger K; Gires O
    Sci Rep; 2018 Oct; 8(1):14582. PubMed ID: 30275505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer.
    Lee HH; Lee SH; Song KY; Na SJ; O JH; Park JM; Jung ES; Choi MG; Park CH
    BMC Cancer; 2017 Oct; 17(1):670. PubMed ID: 28974196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma.
    Zheng M; Jiang YP; Chen W; Li KD; Liu X; Gao SY; Feng H; Wang SS; Jiang J; Ma XR; Cen X; Tang YJ; Chen Y; Lin YF; Tang YL; Liang XH
    Oncotarget; 2015 Mar; 6(9):6797-810. PubMed ID: 25762643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug.
    Chung MK; Jung YH; Lee JK; Cho SY; Murillo-Sauca O; Uppaluri R; Shin JH; Sunwoo JB
    Clin Cancer Res; 2018 Feb; 24(3):674-683. PubMed ID: 29208672
    [No Abstract]   [Full Text] [Related]  

  • 15. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
    Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
    Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated LSD1 and SNAIL Expression Indicate Poor Prognosis in Hypopharynx Carcinoma.
    Bottner J; Ribbat-Idel J; Klapper L; Jagomast T; Lemster AL; Perner S; Idel C; Kirfel J
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slug (SNAI2) expression in oral SCC cells results in altered cell-cell adhesion and increased motility.
    Katafiasz D; Smith LM; Wahl JK
    Cell Adh Migr; 2011; 5(4):315-22. PubMed ID: 21785273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
    Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
    Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of SOX4 and epithelial-mesenchymal transition markers in patients with laryngeal squamous cell carcinoma.
    Zhang M; Li H; Han Y; Wang M; Zhang J; Ma S
    Auris Nasus Larynx; 2021 Dec; 48(6):1167-1175. PubMed ID: 34001394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
    Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
    Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.